About Lawrence Greer
Form D filings for Amytrx Therapeutics from 2015 to 2024 list Lawrence Greer as director.
Lawrence Greer first appears on SEC filings in 2015.
Experience
This experience comes from SEC filings. The years are when the filings name Lawrence Greer in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Lawrence Greer works with at each company, as listed on that company's latest Form D.
Amytrx Therapeutics, Inc. · Form D, Jan 31, 2024
MG
Matthew Gonda
President and CEO, director
SJ
Satish Joshi
Director
MH
Michael Howell
Director
DC
Dennis Carlo
Director
RP
Raymond Pirtle
Director